Serologic rebounds after one-year-long treatment for congenital toxoplasmosis

Pediatr Infect Dis J. 2000 Jan;19(1):81-3. doi: 10.1097/00006454-200001000-00018.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Protozoan / blood*
  • Antiprotozoal Agents / administration & dosage*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunoglobulin A / blood
  • Immunoglobulin M / blood
  • Infant, Newborn
  • Male
  • Pregnancy
  • Prognosis
  • Pyrimethamine / administration & dosage*
  • Retrospective Studies
  • Serologic Tests
  • Sulfadiazine / administration & dosage*
  • Toxoplasmosis, Congenital / diagnosis*
  • Toxoplasmosis, Congenital / drug therapy*

Substances

  • Antibodies, Protozoan
  • Antiprotozoal Agents
  • Immunoglobulin A
  • Immunoglobulin M
  • Sulfadiazine
  • Pyrimethamine